BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Latest DEFS14A SEC Filings
Definitive proxy statement for special meeting

CEL SCI CORP, DEFS14A, 2001-01-19
GILEAD SCIENCES INC, DEFS14A, 2000-12-20
IGI INC, DEFS14A, 2000-09-01
HYBRIDON INC, DEFS14A, 2000-08-15
ABGENIX INC, DEFS14A, 2000-07-27
CEL SCI CORP, DEFS14A, 1999-03-22
ADVANCED TISSUE SCIENCES INC, DEFS14A, 1998-12-21
INTERFERON SCIENCES INC, DEFS14A, 1998-12-07
AMERICAN BIOGENETIC SCIENCES INC, DEFS14A, 1998-10-14
ORAVAX INC /DE/, DEFS14A, 1998-02-02
MEDAREX INC, DEFS14A, 1998-01-08
HYBRIDON INC, DEFS14A, 1997-11-04
APHTON CORP, DEFS14A, 1997-10-08
PROCEPT INC, DEFS14A, 1997-09-08
AMBI INC, DEFS14A, 1997-06-03
SERAGEN INC, DEFS14A, 1996-11-19
GENTA INCORPORATED /DE/, DEFS14A, 1996-08-22
MEDIMMUNE INC /DE, DEFS14A, 1996-07-15
CYTRX CORP, DEFS14A, 1995-12-19
INTERFERON SCIENCES INC, DEFS14A, 1995-08-04


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission